Skip to main content
Erschienen in: Supportive Care in Cancer 3/2020

15.06.2019 | Original Article

The prevalence of patient-reported dysphagia and oral complications in cancer patients

verfasst von: Jacqui Frowen, Rhys Hughes, Jemma Skeat

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Research investigating swallowing problems (dysphagia) and complications within the oral cavity in non-head and neck cancer patients is limited. The purpose of this study was to determine the prevalence of patient-reported dysphagia and oral complications in all cancer patients and to examine the relationships between cancer types, oral complications and dysphagia.

Methods

A cross-sectional study was conducted at a specialist cancer centre in Australia. Data on patient-reported dysphagia and oral complications were collected using the Vanderbilt Head and Neck Symptom Survey (version 2.0) which was completed by participants in one of three settings: inpatients, ambulatory patients receiving chemotherapy, or ambulatory patients receiving radiotherapy.

Results

Data were collected on 239 patients, receiving treatment for 14 cancer types. The proportion of patients who reported dysphagic symptoms were as follows: any dysphagia (54%); dysphagia for liquids (20%); and dysphagia for solids (46%). Significantly more head and neck patients and significantly fewer breast patients reported dysphagia, but there were no differences between other tumour types. Oral symptoms across all cancer types were reported at the following rates: taste changes (62%); xerostomia (56%); voice changes (37%); smell changes (35%); thick mucous (33%); difficulty with teeth/dentures (25%); mouth/throat pain (20%); and trismus (19%).

Conclusions

This is the first time comprehensive data on dysphagia and oral complications across all cancer patients have been collected. We have identified that dysphagic symptoms and oral complications—which have implications for quality of life and function—are common in all cancer patients, not just those with head and neck cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wong HM (2014) Oral complications and management strategies for patients undergoing cancer therapy. Sci World J 2014:1–14 Wong HM (2014) Oral complications and management strategies for patients undergoing cancer therapy. Sci World J 2014:1–14
2.
Zurück zum Zitat Epstein JB, Thariat J, Bensadoun RJ, Barasch A, Murphy BA, Kolnick L, Popplewell L, Maghami E (2012) Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin 62(6):400–422PubMedCrossRef Epstein JB, Thariat J, Bensadoun RJ, Barasch A, Murphy BA, Kolnick L, Popplewell L, Maghami E (2012) Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin 62(6):400–422PubMedCrossRef
3.
Zurück zum Zitat Feng F, Kim H, Lynden T, Haxer M, Feng M, Worden F, Chepeha D, Eisbruch A (2007) Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 68(5):1289–1298PubMedCrossRef Feng F, Kim H, Lynden T, Haxer M, Feng M, Worden F, Chepeha D, Eisbruch A (2007) Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 68(5):1289–1298PubMedCrossRef
4.
Zurück zum Zitat Rosenthal D, Lewin J, Eisbruch A (2006) Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol 24(17):2636–2643PubMedCrossRef Rosenthal D, Lewin J, Eisbruch A (2006) Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol 24(17):2636–2643PubMedCrossRef
5.
Zurück zum Zitat Murphy BA, Gilbert J (2009) Dysphagia in head and neck cancer patients treated with radiation: assessment, sequelae, and rehabilitation. In: Seminars in radiation oncology, vol 1. Elsevier, pp 35–42 Murphy BA, Gilbert J (2009) Dysphagia in head and neck cancer patients treated with radiation: assessment, sequelae, and rehabilitation. In: Seminars in radiation oncology, vol 1. Elsevier, pp 35–42
6.
Zurück zum Zitat Patterson JM, McColl E, Carding PN, Hildreth AJ, Kelly C, Wilson JA (2014) Swallowing in the first year after chemoradiotherapy for head and neck cancer: clinician-and patient-reported outcomes. Head Neck 36(3):352–358PubMedCrossRef Patterson JM, McColl E, Carding PN, Hildreth AJ, Kelly C, Wilson JA (2014) Swallowing in the first year after chemoradiotherapy for head and neck cancer: clinician-and patient-reported outcomes. Head Neck 36(3):352–358PubMedCrossRef
7.
Zurück zum Zitat van der Laan HP, Bijl HP, Steenbakkers RJ, van der Schaaf A, Chouvalova O, Vemer-van den Hoek JG, Gawryszuk A, van der Laan BF, Oosting SF, Roodenburg JL (2015) Acute symptoms during the course of head and neck radiotherapy or chemoradiation are strong predictors of late dysphagia. Radiother Oncol 115(1):56–62PubMedCrossRef van der Laan HP, Bijl HP, Steenbakkers RJ, van der Schaaf A, Chouvalova O, Vemer-van den Hoek JG, Gawryszuk A, van der Laan BF, Oosting SF, Roodenburg JL (2015) Acute symptoms during the course of head and neck radiotherapy or chemoradiation are strong predictors of late dysphagia. Radiother Oncol 115(1):56–62PubMedCrossRef
8.
Zurück zum Zitat Moroney LB, Helios J, Ward EC, Crombie J, Wockner LF, Burns CL, Spurgin A-L, Blake C, Kenny L, Hughes BG (2017) Patterns of dysphagia and acute toxicities in patients with head and neck cancer undergoing helical IMRT±concurrent chemotherapy. Oral Oncol 64:1–8PubMedCrossRef Moroney LB, Helios J, Ward EC, Crombie J, Wockner LF, Burns CL, Spurgin A-L, Blake C, Kenny L, Hughes BG (2017) Patterns of dysphagia and acute toxicities in patients with head and neck cancer undergoing helical IMRT±concurrent chemotherapy. Oral Oncol 64:1–8PubMedCrossRef
9.
Zurück zum Zitat Barnhart MK, Robinson RA, Simms VA, Ward EC, Cartmill B, Chandler SJ, Smee RI (2018) Treatment toxicities and their impact on oral intake following non-surgical management for head and neck cancer: a 3-year longitudinal study. Support Care Cancer 26(7):2341–2351PubMedCrossRef Barnhart MK, Robinson RA, Simms VA, Ward EC, Cartmill B, Chandler SJ, Smee RI (2018) Treatment toxicities and their impact on oral intake following non-surgical management for head and neck cancer: a 3-year longitudinal study. Support Care Cancer 26(7):2341–2351PubMedCrossRef
10.
Zurück zum Zitat De Ruysscher D, Dehing C, Bremer R, Bentzen S, Koppe F, Pijls-Johannesma M, Harzée L, Minken A, Wanders R, Hochstenbag M (2007) Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. Ann Oncol 18(5):909–916PubMedCrossRef De Ruysscher D, Dehing C, Bremer R, Bentzen S, Koppe F, Pijls-Johannesma M, Harzée L, Minken A, Wanders R, Hochstenbag M (2007) Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. Ann Oncol 18(5):909–916PubMedCrossRef
11.
Zurück zum Zitat Dehing-Oberije C, De Ruysscher D, Petit S, Van Meerbeeck J, Vandecasteele K, De Neve W, Dingemans AMC, El Naqa I, Deasy J, Bradley J (2010) Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients. Radiother Oncol 97(3):455–461PubMedCrossRef Dehing-Oberije C, De Ruysscher D, Petit S, Van Meerbeeck J, Vandecasteele K, De Neve W, Dingemans AMC, El Naqa I, Deasy J, Bradley J (2010) Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients. Radiother Oncol 97(3):455–461PubMedCrossRef
12.
Zurück zum Zitat Brady GC, Roe JW, O’Brien M, Boaz A, Shaw C (2018) An investigation of the prevalence of swallowing difficulties and impact on quality of life in patients with advanced lung cancer. Support Care Cancer 26(2):515–519PubMedCrossRef Brady GC, Roe JW, O’Brien M, Boaz A, Shaw C (2018) An investigation of the prevalence of swallowing difficulties and impact on quality of life in patients with advanced lung cancer. Support Care Cancer 26(2):515–519PubMedCrossRef
13.
Zurück zum Zitat Mercadante S, Aielli F, Adile C, Ferrera P, Valle A, Fusco F, Caruselli A, Cartoni C, Massimo P, Masedu F (2015) Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients. Support Care Cancer 23(11):3249–3255PubMedCrossRef Mercadante S, Aielli F, Adile C, Ferrera P, Valle A, Fusco F, Caruselli A, Cartoni C, Massimo P, Masedu F (2015) Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients. Support Care Cancer 23(11):3249–3255PubMedCrossRef
14.
Zurück zum Zitat Raber-Durlacher JE, Brennan MT, Verdonck-de Leeuw IM, Gibson RJ, Eilers JG, Waltimo T, Bots CP, Michelet M, Sollecito TP, Rouleau TS (2012) Swallowing dysfunction in cancer patients. Support Care Cancer 20(3):433–443PubMedCrossRef Raber-Durlacher JE, Brennan MT, Verdonck-de Leeuw IM, Gibson RJ, Eilers JG, Waltimo T, Bots CP, Michelet M, Sollecito TP, Rouleau TS (2012) Swallowing dysfunction in cancer patients. Support Care Cancer 20(3):433–443PubMedCrossRef
16.
Zurück zum Zitat Vera-Llonch M, Oster G, Hagiwara M, Sonis S (2006) Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma: risk factors and clinical consequences. Cancer 106(2):329–336PubMedCrossRef Vera-Llonch M, Oster G, Hagiwara M, Sonis S (2006) Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma: risk factors and clinical consequences. Cancer 106(2):329–336PubMedCrossRef
17.
Zurück zum Zitat Dirix P, Nuyts S, Van den Bogaert W (2006) Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer 107(11):2525–2534PubMedCrossRef Dirix P, Nuyts S, Van den Bogaert W (2006) Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer 107(11):2525–2534PubMedCrossRef
18.
Zurück zum Zitat Pinna R, Campus G, Cumbo E, Mura I, Milia E (2015) Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage. Ther Clin Risk Manag 11:171PubMedPubMedCentralCrossRef Pinna R, Campus G, Cumbo E, Mura I, Milia E (2015) Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage. Ther Clin Risk Manag 11:171PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Lee R, Slevin N, Musgrove B, Swindell R, Molassiotis A (2012) Prediction of post-treatment trismus in head and neck cancer patients. Br J Oral Maxillofac Surg 50(4):328–332PubMedCrossRef Lee R, Slevin N, Musgrove B, Swindell R, Molassiotis A (2012) Prediction of post-treatment trismus in head and neck cancer patients. Br J Oral Maxillofac Surg 50(4):328–332PubMedCrossRef
20.
Zurück zum Zitat Bensadoun R-J, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FK, Brennan MT (2010) A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer 18(8):1033–1038PubMedCrossRef Bensadoun R-J, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FK, Brennan MT (2010) A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer 18(8):1033–1038PubMedCrossRef
21.
Zurück zum Zitat Epstein JB, Emerton S, Kolbinson DA, Le ND, Phillips N, Stevenson-Moore P, Osoba D (1999) Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 21(1):1–11PubMedCrossRef Epstein JB, Emerton S, Kolbinson DA, Le ND, Phillips N, Stevenson-Moore P, Osoba D (1999) Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 21(1):1–11PubMedCrossRef
22.
Zurück zum Zitat Langius A, Lind M (1995) Well-being and coping in oral and pharyngeal cancer patients. Eur J Cancer B Oral Oncol 31(4):242–249CrossRef Langius A, Lind M (1995) Well-being and coping in oral and pharyngeal cancer patients. Eur J Cancer B Oral Oncol 31(4):242–249CrossRef
23.
Zurück zum Zitat Bjordal K, Freng A, Thorvik J, Kaasa S (1995) Patient self-reported and clinician-rated quality of life in head and neck cancer patients: a cross-sectional study. Eur J Cancer B Oral Oncol 31(4):235–241CrossRef Bjordal K, Freng A, Thorvik J, Kaasa S (1995) Patient self-reported and clinician-rated quality of life in head and neck cancer patients: a cross-sectional study. Eur J Cancer B Oral Oncol 31(4):235–241CrossRef
24.
Zurück zum Zitat Hovan AJ, Williams PM, Stevenson-Moore P, Wahlin YB, KEO O, Elting LS, Spijkervet FKL, Brennan MT, Dysgeusia Section OCSG, Multinational Association of Supportive Care in Cancer /International Society of Oral Oncology (2010) A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18(8):1081–1087. https://doi.org/10.1007/s00520-010-0902-1 PubMedCrossRef Hovan AJ, Williams PM, Stevenson-Moore P, Wahlin YB, KEO O, Elting LS, Spijkervet FKL, Brennan MT, Dysgeusia Section OCSG, Multinational Association of Supportive Care in Cancer /International Society of Oral Oncology (2010) A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18(8):1081–1087. https://​doi.​org/​10.​1007/​s00520-010-0902-1 PubMedCrossRef
25.
Zurück zum Zitat Bernhardson B-M, Tishelman C, Rutqvist LE (2008) Self-reported taste and smell changes during cancer chemotherapy. Support Care Cancer 16(3):275–283PubMedCrossRef Bernhardson B-M, Tishelman C, Rutqvist LE (2008) Self-reported taste and smell changes during cancer chemotherapy. Support Care Cancer 16(3):275–283PubMedCrossRef
26.
Zurück zum Zitat Lalla RV, Sonis ST, Peterson DE (2008) Management of oral mucositis in patients who have cancer. Dent Clin N Am 52(1):61–77PubMedCrossRef Lalla RV, Sonis ST, Peterson DE (2008) Management of oral mucositis in patients who have cancer. Dent Clin N Am 52(1):61–77PubMedCrossRef
27.
Zurück zum Zitat Jensen SB, Mouridsen HT, Reibel J, Brünner N, Nauntofte B (2008) Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction. Oral Oncol 44(2):162–173PubMedCrossRef Jensen SB, Mouridsen HT, Reibel J, Brünner N, Nauntofte B (2008) Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction. Oral Oncol 44(2):162–173PubMedCrossRef
28.
Zurück zum Zitat Jensen SB, Pedersen AML, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN (2010) A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer 18(8):1039–1060PubMedCrossRef Jensen SB, Pedersen AML, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN (2010) A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer 18(8):1039–1060PubMedCrossRef
29.
Zurück zum Zitat Bressan V, Stevanin S, Bianchi M, Aleo G, Bagnasco A, Sasso L (2016) The effects of swallowing disorders, dysgeusia, oral mucositis and xerostomia on nutritional status, oral intake and weight loss in head and neck cancer patients: a systematic review. Cancer Treat Rev 45:105–119PubMedCrossRef Bressan V, Stevanin S, Bianchi M, Aleo G, Bagnasco A, Sasso L (2016) The effects of swallowing disorders, dysgeusia, oral mucositis and xerostomia on nutritional status, oral intake and weight loss in head and neck cancer patients: a systematic review. Cancer Treat Rev 45:105–119PubMedCrossRef
30.
Zurück zum Zitat Cooperstein E, Gilbert J, Epstein JB, Dietrich MS, Bond SM, Ridner SH, Wells N, Cmelak A, Murphy BA (2012) Vanderbilt Head and Neck Symptom Survey version 2.0: report of the development and initial testing of a subscale for assessment of oral health. Head Neck 34(6):797–804PubMedCrossRef Cooperstein E, Gilbert J, Epstein JB, Dietrich MS, Bond SM, Ridner SH, Wells N, Cmelak A, Murphy BA (2012) Vanderbilt Head and Neck Symptom Survey version 2.0: report of the development and initial testing of a subscale for assessment of oral health. Head Neck 34(6):797–804PubMedCrossRef
31.
Zurück zum Zitat Vainshtein JM, Samuels S, Tao Y, Lyden T, Haxer M, Spector M, Schipper M, Eisbruch A (2016) Impact of xerostomia on dysphagia after chemotherapy–intensity-modulated radiotherapy for oropharyngeal cancer: prospective longitudinal study. Head Neck 38(S1):E1605–E1612PubMedCrossRef Vainshtein JM, Samuels S, Tao Y, Lyden T, Haxer M, Spector M, Schipper M, Eisbruch A (2016) Impact of xerostomia on dysphagia after chemotherapy–intensity-modulated radiotherapy for oropharyngeal cancer: prospective longitudinal study. Head Neck 38(S1):E1605–E1612PubMedCrossRef
32.
33.
Zurück zum Zitat Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper C, Cooper B, Dubberke ER, Engemann AM, Freifeld AG (2016) Prevention and treatment of cancer-related infections, version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw 14(7):882–913CrossRef Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper C, Cooper B, Dubberke ER, Engemann AM, Freifeld AG (2016) Prevention and treatment of cancer-related infections, version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw 14(7):882–913CrossRef
34.
Zurück zum Zitat Xu B, Boero IJ, Hwang L, Le QT, Moiseenko V, Sanghvi PR, Cohen EE, Mell LK, Murphy JD (2015) Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer. Cancer 121(8):1303–1311PubMedCrossRef Xu B, Boero IJ, Hwang L, Le QT, Moiseenko V, Sanghvi PR, Cohen EE, Mell LK, Murphy JD (2015) Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer. Cancer 121(8):1303–1311PubMedCrossRef
35.
Zurück zum Zitat Van Cutsem E, Arends J (2005) The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 9:S51–S63PubMedCrossRef Van Cutsem E, Arends J (2005) The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 9:S51–S63PubMedCrossRef
36.
Zurück zum Zitat Osoba D (2007) Health-related quality of life and predicting survival in cancer: not a simple matter. Support Care Cancer 15:353–355PubMedCrossRef Osoba D (2007) Health-related quality of life and predicting survival in cancer: not a simple matter. Support Care Cancer 15:353–355PubMedCrossRef
37.
38.
Zurück zum Zitat Elad S, Zadik Y, Yarom N (2017) Oral complications of nonsurgical cancer therapies. Atlas Oral Maxillofac Surg Clin N Am 25(2):133–147CrossRef Elad S, Zadik Y, Yarom N (2017) Oral complications of nonsurgical cancer therapies. Atlas Oral Maxillofac Surg Clin N Am 25(2):133–147CrossRef
40.
Zurück zum Zitat Sreedharan A, Harris K, Crellin A, Forman D, Everett SM (2009) Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev 4 Sreedharan A, Harris K, Crellin A, Forman D, Everett SM (2009) Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev 4
41.
Zurück zum Zitat Logemann J, Larsen K (2012) Oropharyngeal dysphagia: pathophysiology and diagnosis for the anniversary issue of Diseases of the Esophagus. Dis Esophagus 25(4):299–304PubMedCrossRef Logemann J, Larsen K (2012) Oropharyngeal dysphagia: pathophysiology and diagnosis for the anniversary issue of Diseases of the Esophagus. Dis Esophagus 25(4):299–304PubMedCrossRef
43.
Zurück zum Zitat World Health Organization (1979) WHO handbook for reporting results of cancer treatment. World Health Organization, Geneva World Health Organization (1979) WHO handbook for reporting results of cancer treatment. World Health Organization, Geneva
44.
Zurück zum Zitat Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L, Zilberberg MD (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66(3):253–262PubMedCrossRef Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L, Zilberberg MD (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66(3):253–262PubMedCrossRef
45.
Zurück zum Zitat Logemann JA, Pauloski BR, Rademaker AW, Lazarus CL, Mittal B, Gaziano J, Stachowiak L, MacCracken E, Newman LA (2003) Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck 25(6):432–437PubMedCrossRef Logemann JA, Pauloski BR, Rademaker AW, Lazarus CL, Mittal B, Gaziano J, Stachowiak L, MacCracken E, Newman LA (2003) Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck 25(6):432–437PubMedCrossRef
Metadaten
Titel
The prevalence of patient-reported dysphagia and oral complications in cancer patients
verfasst von
Jacqui Frowen
Rhys Hughes
Jemma Skeat
Publikationsdatum
15.06.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 3/2020
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04921-y

Weitere Artikel der Ausgabe 3/2020

Supportive Care in Cancer 3/2020 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.